Addiction to alcohol and illicit drugs is the third leading cause of preventable death in the United States. It is well known that genetic factors play a major role in the development of addiction, and many of these factors appear to contribute to a generalized liability for addiction. However, environmental factors also play important roles, and there is abundant evidence that a number of environmental factors may alter the effect of genetic risk factors. Hence, it is critical to approach addictive disease using a gene-environment approach. ? ? We propose to undertake a comprehensive genome-wide association study using nearly 3,000 unrelated subjects of European descent in a case-control design and to analyze genetic associations and gene x environment interactions. Cases include 1,333 subjects with the primary phenotype of DSM-IV alcohol dependence, and often with other comorbid drug addiction. Controls comprise 1,647 subjects who have used alcohol, but have never been addicted to alcohol, nicotine, or other illicit substances. This approach to control status will ensure that genetic findings are related to substance dependence, rather than the initiation of substance use. The large number of subjects is made feasible by a cross-study collaboration involving three major studies of addictive disorders: the Collaborative Study on the Genetics of Alcoholism (COGA), the Family Study of Cocaine Dependence (FSCD), and the Collaborative Genetic Study of Nicotine Dependence (COGEND). All these studies participate in the NIAAA and NIDA Genetic Repositories. ? ? Our primary goals of this proposal are to undertake large-scale genotyping through the Genes and Environment Initiative (GEI) sequencing center, to standardize and harmonize phenotypic and environmental variables across all studies, and to perform a logical and sequential set of analyses that will incorporate covariates and environmental features for the testing of genetic association, gene-environment and gene-gene interactions. Finally, we will seek to replicate and extend findings from this genome-wide association study in an African-American population with over 1300 subjects (760 cases and 485 controls). Other independent and genetically informative datasets, including two data sets collected by COGA, and three large data sets held by collaborating investigators, provide the opportunity to further investigate genetic findings. ? ? This study will be the first to systematically address both genetic and environmental effects in addiction to using a genome-wide association approach; novel features include the integration of multiple large-scale data sets, a carefully considered definition of control status, and the opportunity for replication in several independent samples. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01HG004422-01
Application #
7327188
Study Section
Special Emphasis Panel (ZHG1-HGR-P (M1))
Program Officer
Wise, Anastasia Leigh
Project Start
2007-08-06
Project End
2009-05-31
Budget Start
2007-08-06
Budget End
2008-05-31
Support Year
1
Fiscal Year
2007
Total Cost
$561,473
Indirect Cost
Name
Washington University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Wang, Kesheng; Chen, Xue; Ward, Stephen C et al. (2018) CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. Int J Obes (Lond) :
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Liu, Dungang; Zhang, Heping (2018) Residuals and Diagnostics for Ordinal Regression Models: A Surrogate Approach. J Am Stat Assoc 113:845-854
Glasheen, Cristie; Johnson, Eric O; Saccone, Nancy L et al. (2018) Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. Drug Alcohol Depend 185:127-132
Cabana-Domínguez, Judit; Arenas, Concepció; Cormand, Bru et al. (2018) MiR-9, miR-153 and miR-124 are down-regulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence. Transl Psychiatry 8:173
Jensen, K P; Smith, A H; Herman, A I et al. (2017) A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. Mol Psychiatry 22:242-249
Wang, Jian; Talluri, Rajesh; Shete, Sanjay (2017) Selection of X-chromosome Inactivation Model. Cancer Inform 16:1176935117747272
Wang, Minghui; Huang, Jianfei; Liu, Yiyuan et al. (2017) COMBAT: A Combined Association Test for Genes Using Summary Statistics. Genetics 207:883-891
Martínez-Rivera, A; Hao, J; Tropea, T F et al. (2017) Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Mol Psychiatry 22:1735-1745
Hartz, Sarah M; Horton, Amy C; Oehlert, Mary et al. (2017) Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. Biol Psychiatry 82:709-715

Showing the most recent 10 out of 170 publications